Shamir R. Mehta - Researcher Profile

Publications

5 shown

Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome

Keith A.A. Fox , Shamir R. Mehta , Ron J.G. Peters +4 more

Background— Antiplatelet therapy and antithrombin therapy have been demonstrated to reduce the risk of cardiac events in patients presenting with acute coronary syndrome, yet al...

2004 Circulation 831 citations

Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention

Shamir R. Mehta , Salim Yusuf

2003 Journal of the American College of Ca... 97 citations

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Shamir R. Mehta , Salim Yusuf , Ron J.G. Peters +7 more

2001 The Lancet 2789 citations

Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial

Shamir R. Mehta , Susan Chrolavicius , Rizwan Afzal +9 more

ClinicalTrials.gov Identifier NCT00064428.

2006 JAMA 903 citations

Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes

Salim Yusuf , Shamir R. Mehta , Feng Zhao +6 more

Background— The risk of ischemic events is high, both early and late after acute coronary syndromes (ACS). We examine the benefits and risks associated with the use of adding cl...

2003 Circulation 302 citations

Frequent Co-Authors

Researcher Info

h-index: 5
Publications: 5
Citations: 4,922
Institution: McMaster University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-3258-949X

Impact Metrics

h-index 5

h-index: Number of publications with at least h citations each.